The Scientific World Journal

Volume 2013 (2013), Article ID 245828, 4 pages

http://dx.doi.org/10.1155/2013/245828

Research Article

Acute Toxicity and Genotoxic Activity of Avocado Seed Extract (Persea americana Mill., c.v. Hass)

Eduardo Padilla-Camberos, Moisés Martínez-Velázquez, José Miguel Flores-Fernández, and Socorro Villanueva-Rodríguez

Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, A.C., Avenida Normalistas 800, Colonia Colinas de la Normal, Guadalajara 44270, JAL, Mexico

Received 30 August 2013; Accepted 23 September 2013

Academic Editors: D. Matthopoulos and I. V. Sharakhov

Copyright © 2013 Eduardo Padilla-Camberos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

The use of vegetal extracts requires toxicological and genotoxic evaluations to establish and verify safety before being added to human cosmetic, pharmaceutical medicine, or alimentary products. Persea americana seeds have been used in traditional medicine as treatment for several diseases. In this work, the ethanolic seed extract of Persea americana was evaluated with respect to its genotoxic potential through micronucleus assay in rodents. The frequency of micronuclei in groups of animals treated with avocado seed extract showed no differences compared to the negative control (vehicle); therefore, it is considered that the avocado seed extract showed no genotoxic activity in the micronucleus test.

1. Introduction

The fruit of Persea americana, commonly known as avocado, is an edible fruit from Central America which is easily adaptable in tropical regions [1]. The avocado has an olive-green peel and thick pale yellow pulp that is rich in fatty acids such as linoleic, oleic, palmitic, stearic, linolenic, capric, and myristic acids. This fruit is normally used for human consumption, but it also has been used as a medicinal plant in Mexico and elsewhere in the world [2].

The avocado seed represents 13–18% of the fruit, and it is a byproduct generally not utilized. Normally, the seed is discarded during the processing of the pulp. The seed waste may represent a severe ecological problem [3]. However, at the same time, it may be of interest to industry as a source of bioactive compounds. Its chemical composition is comprised of phytosterols, triterpenes, fatty acids, and two new glucosides of abscisic acid [4].

Several biological activities of the avocado seed have been reported such as antioxidant, antihypertensive, larvicidal, fungicidal, hypolipidemic, and recently amoebicidal and giardicidal activities [5–8]. Additionally, several studies have focused on the evaluation of acute toxicity of the fruit and leaves [9]. Avocado leaves showed cardiotoxic effects in mammals and birds [10–13]. Similarly, the mutagenicity of fruit and leaves extracts in human lymphocytes has been assessed [14]. However, no study has been done to examine the possible genotoxic activity of avocado seed extract. In this study, we evaluate the genotoxic effect of a P. americana seed extract in vivo, by induction of micronuclei in blood polychromatic erythrocytes of BALB/c mice.

2. Materials and Methods

2.1. Plant Material

Avocados were purchased from Michoacán, Mexico. The seeds were dried at 40°C and vacuum packaged until use.

2.2. Avocado Seed Extract

The P. americana seed extract is an ethanolic extract obtained through soxhlet reflux equipment and evaporated on a rotary evaporator as mentioned by Ramos et al. in 2004 [4]. Dried avocado seeds (1600 g) were ground to powder in a laboratory mill, defatted with petrol ether (55–75°C), and macerated with freshly distilled ethanol until exhaustion. After filtration, extracts were concentrated under vacuum at 35°C.

2.3. Animals

Forty-five, eight-week-old male BALB/c mice (23 ± 2 g) were purchased from the Zooterio of the University of Guadalajara. The mice were fed Standard Diet 20128 Tekland and water. They were kept at room temperature under a 12 hours of light and 12 hours of dark cycle at 22°C. Thirty mice were employed for acute toxicity test and fifteen mice for genotoxicity test. Animals were handled following the animal care guidelines in accordance with regulations enacted by the Federal Government of Mexico (NOM-062-ZOO-1999 and NOM-033-ZOO-1995).

2.4. Acute Toxicity Test

To determine the median lethal dose (LD₅₀) of the P. americana seed extract, six groups of 5 mice each were administered one by one by oral gavage at different doses consisting of 125, 250, 500, 1000, and 2000 mg/kg using an orogastric tube (Popper). Mortality was recorded 24 hours after the administration of the extract. Animals were observed during one week to detect signs of delayed toxicity.

2.5. Genotoxicity Test

The genotoxicological study of the P. americana seed extract was carried out using an identification and quantification on the erythrocyte micronucleus formation test. According to the acute toxicity test results, the most appropriate extract dose for genotoxic study was selected. Three groups of 5 mice each were employed in the experiment. The first group was given P. americana seed extract at a dose of 250 mg/kg, dissolved in 1 : 1 alcohol-water solution; the second group was given colchicine dissolved in physiological saline at a dose of 4 mg/kg and was designated as the positive control, while the third group was assigned as the negative control and received the vehicle (1 : 1 alcohol-water solution), all solutions in an amount of 1 mL/kg. At 36 hours after administration of treatments, peripheral blood samples were collected by perforating the caudal vein, and drops were placed at the prestained slides with acridine orange as described by Hayashi and Sofuni, 1994 [15]. The micronucleated cells were scored under a fluorescence microscope. 1000 peripheral reticulocytes per mouse were analyzed, and the frequencies of micronucleated peripheral reticulocytes were scored in three slides per animal [16].

2.6. Statistical Analyses

LD₅₀ value was determined through Probit analysis [17]. One-way ANOVA multicomparisons tests were used to identify any significant difference among genotoxicity tests between animal groups, and Fisher’s least significant difference (LSD) was used to compare significant differences between groups. A value < 0.05 was considered statistically significant. All data was analyzed using the software Statgraphics Version XVI.I.

3. Results

3.1. Acute Toxicity

The P. americana seed extract administrated at doses of 500, 1000, and 2000 mg/Kg showed a mortality of 20, 60, and 80%, respectively. The animal groups treated with 125 and 250 mg/Kg, as well as the control group, showed no mortality (Figure 1). The LD₅₀ calculated for the avocado seed extract was 1200.75 mg/kg. According to these results, a concentration of 250 mg/Kg was determined for genotoxicity testing.

Figure 1: Percentage of mortality for determining the acute toxicity of the P. americana seed extract.

3.2. Genotoxicity Test

The animal groups administered with 250 mg/Kg of P. americana seed extract and the negative control group showed a low amount of micronucleated cells, while the positive control administered with colchicine showed clear evidence of harm. There is no statistically significant difference between the group administered with the extract of P. americana seed and control group; however, there is a significant difference between both these groups in regard to the positive control (Table 1).

Table 1: Micronucleated peripheral reticulocytes (MNRET) formed by P. americana seed extract.

Samples
Dose (mg/kg)
MNRET/1000 RET

Number
%

Alcohol-water solution

P. americana seed extract
250

Colchicine
4

The data are presented as mean standard deviation of three repetitions. Asterisks denote statistical differences compared with control ().

4. Discussion

The avocado (P. americana) is consumed by humans because of its organoleptic characteristics; furthermore, the pulp contains up to 33% oil, rich in monounsaturated fatty acids [3]. The avocado seed is discarded in the majority of countries, although in some countries such as Niger, it is consumed [18, 19]. This waste may represent an ecological or human contaminant.

In a study previously reported on acute and subacute toxicity of a P. americana aqueous extract, it was not possible to estimate the LD₅₀ value with the doses tested (up to 10 g/kg). Also, in repeated doses, toxicity tests during 28 days showed no affectations in hematological and biochemical parameters. Therefore, the authors concluded that the aqueous extract appears safe at least on an acute and sub-acute basis [9]. We showed that the ethanolic extract of P. americana seed presents acute toxicity with a LD₅₀ value of 1200.75 mg/kg. The acute toxicity differences found in the aqueous and ethanolic extracts may be due to chemical components obtained by different extraction methods used.

Micronucleus is an excellent genotoxic biomarker [15, 20]; therefore, the staining technique with acridine orange helps differentiate micronucleated cells. The evaluation of micronucleus frequencies in vivo is one of the primary genotoxicity tests recommended internationally by regulatory agencies for product safety assessment [21]. Based on the international working group that evaluates the micronucleus test, this should be used when no signs of toxicity at maximal possible concentration are seen [22, 23]. Accordingly, from the acute toxicity test, the dose of 250 mg/kg was selected for the genotoxicity test [24].

This is the first study on the genotoxicity of the ethanolic avocado seed extract. The micronucleus induction with the P. americana seed extract showed no statistical difference with regard to the negative control, but with regard to the positive control it did. Therefore, it is considered that the P. americana seed extract showed no genotoxic activity with the micronucleus test. There is a study that demonstrates the genotoxicity of the avocado fruit and leaf extracts in human peripheral lymphocytes [14]; however, this study was carried out in vitro. There are different toxic effects in vitro and in vivo, especially when it is administered orally.

Reports of genotoxicity have revealed that many plants used as food or in traditional medicine have cytotoxic, mutagenic, and genotoxic properties [25]. This indicates the need to understand the toxicological profile of substances that are in direct or indirect contact with humans.

To complement the toxicological profile of the avocado seed extract, it is also necessary to test for other areas of potential damage, such as those related to the immune system and those that alter endocrine function.

5. Conclusion

The ethanolic extract of the P. americana seed showed an acute toxic effect at concentration starting at 500 mg/kg. In vivo mutagenicity on peripheral blood cells of the seed extract was not observed. However, this study needs to be supported with experimental toxicity studies using isolated compounds. The lack of in vivo genotoxic activity of the extract allows us to hope that the P. americana seed extract could be used as a possible food, cosmetic, or pharmaceutical material.

Conflict of Interests

The authors declare that they have no financial and commercial interests. No conflict of interests has been declared.

Acknowledgment

The authors would like to thank Tina Coop for helping in the translation of this paper into English.

References

J. J. G. Leite, É. H. S. Brito, R. A. Cordeiro et al., “Chemical composition, toxicity and larvicidal and antifungal activities of Persea americana (avocado) seed extracts,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 42, no. 2, pp. 110–113, 2009.

M. L. Dreher and A. J. Davenport, “Hass avocado composition and potential health effects,” Critical Reviews in Food Science and Nutrition, vol. 53, no. 7, pp. 738–750, 2013.

M. A. Ortiz, A. L. Dorantes, M. J. Gallndez, and S. E. Cárdenas, “Effect of a novel oil extraction method on avocado (Persea americana Mill) pulp microstructure,” Plant Foods for Human Nutrition, vol. 59, no. 1, pp. 11–14, 2004.

M. R. Ramos, G. Jerz, S. Villanueva, F. López-Dellamary, R. Waibel, and P. Winterhalter, “Two glucosylated abscisic acid derivates from avocado seeds (Persea americana Mill. Lauraceae cv. Hass),” Phytochemistry, vol. 65, no. 7, pp. 955–962, 2004.

J.-G. Rodríguez-Carpena, D. Morcuende, M.-J. Andrade, P. Kylli, and M. Estevez, “Avocado (Persea americana Mill.) phenolics, in vitro antioxidant and antimicrobial activities, and inhibition of lipid and protein oxidation in porcine patties,” Journal of Agricultural and Food Chemistry, vol. 59, no. 10, pp. 5625–5635, 2011.

O. N. Anaka, R. I. Ozolua, and S. O. Okpo, “Effect of the aqueous seed extract of Persea americana Mill (Lauraceae) on the blood pressure of Sprague-Dawley rats,” African Journal of Pharmacy and Pharmacology, vol. 3, no. 10, pp. 485–490, 2009.

M. E. Pahua-Ramos, A. Ortiz-Moreno, G. Chamorro-Cevallos et al., “Hypolipidemic effect of avocado (Persea americana Mill) seed in a hypercholesterolemic mouse model,” Plant Foods for Human Nutrition, vol. 67, no. 1, pp. 10–16, 2012.

A. Jimenez-Arellanes, J. Luna-Herrera, R. Ruiz-Nicolas, J. Cornejo-Garrido, A. Tapia, and L. Yépez-Mulia, “Antiprotozoal and antimycobacterial activities of Persea americana seeds,” BMC Complementary and Alternative Medicine, vol. 13, article 109, 2013.

R. I. Ozolua, O. N. Anaka, S. O. Okpo, and S. E. Idogun, “Acute and sub-acute toxicological assessment of the aqueous seed extract of Persea americana Mill (Lauraceae) in rats,” African Journal of Traditional, Complementary and Alternative Medicines, vol. 6, no. 4, pp. 573–578, 2009.

R. Grant, P. A. Basson, H. H. Booker, J. B. Hofherr, and M. Anthonissen, “Cardiomyopathy caused by avocado (Persea americana Mill) leaves,” Journal of the South African Veterinary Association, vol. 62, no. 1, pp. 21–22, 1991.

P. Stadler, I. B. van Rensburg, and T. W. Naudé, “Suspected avocado (Persea americana) poisoning in goats,” Journal of the South African Veterinary Association, vol. 62, no. 4, pp. 186–188, 1991.

A. M. Hargis, E. Stauber, S. Casteel, and D. Eitner, “Avocado (Persea americana) intoxication in caged birds,” Journal of the American Veterinary Medical Association, vol. 194, no. 1, pp. 64–66, 1989.

W. P. Burger, T. W. Naudé, I. B. van Rensburg, C. J. Botha, and A. C. Pienaar, “Cardiomyopathy in ostriches (Struthio camelus) due to avocado (Persea americana var. guatemalensis) intoxication,” Journal of the South African Veterinary Association, vol. 65, no. 3, pp. 113–118, 1994.

P. Kulkarni, R. Paul, and N. Ganesh, “In vitro evaluation of genotoxicity of avocado (Persea americana) fruit and leaf extracts in human peripheral lymphocytes,” Journal of Environmental Science and Health C, vol. 28, no. 3, pp. 172–187, 2010.

M. Hayashi and T. Sofuni, “The micronucleus assay with rodent peripheral blood and acridine orange supravital staining,” in Chromosomal Alterations, G. Obe and A. T. Natarajan, Eds., pp. 203–213, Springer, Berlin, Germany, 1994.

C. Promkum, C. Butryee, S. Tuntipopipat, and P. Kupradinun, “Anticlastogenic effect of Eryngium foetidum L. assessed by erythrocyte micronucleus assay,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 1, pp. 3343–3347, 2012.

A. G. Goodman, L. S. Goodman, and A. Gilman, “Principles of toxicology,” in Goodman and Gilman: The Pharmacological Basis of therapeutics, pp. 1602–1603, Macmillan, New York, NY, USA, 6th edition, 1980.

M. A. Owolabi, S. I. Jaja, and H. A. B. Coker, “Vasorelaxant action of aqueous extract of the leaves of Persea americana on isolated thoracic rat aorta,” Fitoterapia, vol. 76, no. 6, pp. 567–573, 2005.

J. Ojewole, D. R. Kamadyaapa, M. M. Gondwe, K. Moodley, and C. T. Musabayane, “Cardiovascular effects of Persea americana Mill (Lauraceae) (avocado) aqueous leaf extract in experimental animals,” Cardiovascular Journal of South Africa, vol. 18, no. 2, pp. 69–76, 2007.

S. Jyoti, S. Khan, M. Afzal, F. Naz, and Y. H. Siddique, “Evaluation of micronucleus frequency by acridine orange fluorescent staining in buccal epithelial cells of oral submucosus fibrosis (OSMF) patients,” The Egyptian Journal of Medical Human Genetics, vol. 14, no. 2, pp. 189–193, 2013.

R. Sahu, G. Divakar, and K. Divakar, “In vivo rodent micronucleus assay of Gmelina arborea roxb (gambhari) extract,” Journal of Advanced Pharmaceutical Technology and Research, vol. 1, no. 1, pp. 22–29, 2010.

M. Kirsch-Volders, T. Sofuni, M. Aardema et al., “Report from the in vitro micronucleus assay working group,” Mutation Research, vol. 540, no. 2, pp. 153–163, 2003.

W. Liu, C. di Giorgio, M. Lamidi, R. Elias, E. Ollivier, and M. P. de Méo, “Genotoxic and clastogenic activity of saponins extracted from Nauclea bark as assessed by the micronucleus and the comet assays in Chinese Hamster Ovary cells,” Journal of Ethnopharmacology, vol. 137, no. 1, pp. 176–183, 2011.

T. Vallarino-Kelly and P. Morales-Ramírez, “Kinetics of micronucleus induction and cytotoxic activity of colchicine in murine erythroblast in vivo,” Mutation Research, vol. 495, no. 1-2, pp. 51–59, 2001.

G. A. Asare, K. Bugyei, A. Sittie, et al., “Genotoxicity, cytotoxicity and toxicological evaluation of whole plant extracts of the medicinal plant Phyllanthus niruri (Phyllanthaceae),” Genetics and Molecular Research, vol. 11, no. 1, pp. 100–111, 2012.